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ABSTRACT
The regulation of gene expression is central to de-
velopmental programs and largely depends on the
binding of sequence-specific transcription factors
with cis-regulatory elements in the genome. Hox
transcription factors specify the spatial coordinates
of the body axis in all animals with bilateral
symmetry, but a detailed knowledge of their mo-
lecular function in instructing cell fates is lacking.
Here, we used chromatin immunoprecipitation with
massively parallel sequencing (ChIP-seq) to identify
Hoxa2 genomic locations in a time and space when
it is actively instructing embryonic development
in mouse. Our data reveals that Hoxa2 has large gen-
ome coverage and potentially regulates thousands
of genes. Sequence analysis of Hoxa2-bound regions
identifies high occurrence of two main classes of
motifs, corresponding to Hox and Pbx–Hox recogni-
tion sequences. Examination of the binding targets of
Hoxa2 faithfully captures the processes regulated by
Hoxa2 during embryonic development; in addition,
it uncovers a large cluster of potential targets
involved in the Wnt-signaling pathway. In vivo exam-
ination of canonical Wnt–b-catenin signaling reveals
activity specifically in Hoxa2 domain of expression,
and this is undetectable in Hoxa2 mutant embryos.
The comprehensive mapping of Hoxa2-binding
sites provides a framework to study Hox regula-
tory networks in vertebrate developmental
processes.
INTRODUCTION
Differential gene transcription instructs the development
of multicellular organisms. A central mechanism to
control gene expression is the binding of sequence-speciﬁc
transcription factors to the genome; DNA–protein inter-
action is mediated by short nucleotide sequences, known
as cis-acting regulatory elements.
Hox transcription factors are sequence-speciﬁc DNA-
binding proteins, encoded by 39 genes in mouse and
human. The organization of Hox genes in clusters (four
clusters in mammals) generates accurate spatio-temporal
patterns of proteins expression across the developing
embryo (1). Throughout the animal kingdom, Hox tran-
scription factors specify the spatial coordinates of the
body axis, to instruct whether a segment of the embryo
will become head, thorax or abdomen (2). Mutations in
single Hox genes can cause spectacular body transform-
ations in Drosophila; and these effects can also occur in
higher organisms, such as mice, but requires inactivation
of multiple Hox genes (3,4).
Despite the recognized role of Hox proteins in embry-
onic development, and increasing evidence supporting
their role in adult homeostasis and disease (5,6), a
detailed knowledge of Hox molecular function in instruct-
ing cell fates is lacking. Few Hox target genes have been
discovered in vertebrates, and the vast majority of
Hox-binding sites in vivo are unknown (7). Hoxa2, a
member of the Hox paralog group 2, controls the fate of
the cranial neural crest that migrates from rhombomere 4
to the second branchial arch (IIBA) in the developing
mouse embryo. Disrupting Hoxa2 function causes loss
of IIBA typical elements, which are instead replaced by
*To whom correspondence should be addressed. Tel: +44 161 3060642; Fax: +44 161 2756636; Email: Nicoletta.Bobola@manchester.ac.uk
3990–4001 Nucleic Acids Research, 2012, Vol. 40, No. 9 Published online 5 January 2012
doi:10.1093/nar/gkr1240
 The Author(s) 2012. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
a duplicated set of ﬁrst branchial arch elements (8–10).
The knowledge of the entire genome sequence together
with next generation sequencing provide an unprecedent-
ed opportunity to understand how binding of Hox tran-
scription factors direct embryonic development. Here, we
have used Hoxa2 chromatin immunoprecipitation coupled
to massively parallel sequencing (ChIP-seq) to identify
genome-wide binding locations of Hoxa2 at a deﬁned
step of IIBA development (Embryonic Day 11.5) in
mouse. Our data reveals that Hoxa2 has large genome
coverage and potentially regulates thousands of genes.
Hoxa2 binding is detected on a considerable fraction of
the genes dysregulated in Hoxa2 mutant embryos at the
same developmental stage (E11.5). We identify a signiﬁ-
cant amount of genes involved in the Wnt-signaling
pathway associated with Hoxa2-bound regions. We
further show tissue- and stage-speciﬁc activation of the
Wnt–b-catenin pathway in the IIBA, which is undetect-
able in Hoxa2 mutant embryos. Our data describe where
Hoxa2 localizes in the genome while functioning to
instruct embryonic development. As such, this study
presents one of the ﬁrst global maps of the in vivo inter-
actions between Hox and chromatin during vertebrate
embryogenesis.
MATERIALS AND METHODS
Mouse husbandry
Hoxa2 mutant mice were described previously (8).
BAT-Gal transgenic mice express nuclear b-galactosidase
under control of multimerized LEF/TCF-binding sites
(11). CD1 mice were time-mated to obtain branchial
arches. Whole mount in situ hybridization and LacZ
staining were carried out as described (12,13), using
Fzd4, Wnt5a (gifts from Lorenz Neidhardt and Rolf
Kemler, respectively), and Hoxa2 probe (14). Animal ex-
periments were carried out under ASPA 1986.
ChIP-seq assays
ChIP assays were carried out as described (15), with the
following modiﬁcations for ChIP-seq. The crosslinked
material was sonicated to 300-bp fragments (Vibracell
sonicator, Sonics: eight times for 10 s at 50% output).
Immunoprecipitation was performed starting from 12
pairs of second branchial arches from E11.5 embryos
and incubating overnight at 4C with 3 mg of anti-Hoxa2
antibody (15) or control IgG, followed by Dynabeads
protein A (Invitrogen). A pool of immunoprecipitated
DNA from eight individual immunoprecipitation (0.5 ng)
was sent for sequencing using the SOLiD 4 platform
according to the manufacturer’s protocols (Life
Technologies). Libraries were prepared according to the
SOLiD ChIP-Seq Kit Guide (MAN0002594) with modiﬁ-
cations outlined in the SOLiD ChIP-Seq Library
Preparation with Barcodes (MAN0003616). Prior to
library preparation the samples were sheared using a
Covaris S2 (Covaris, Inc.) with the protocol recommended
in the Library Preparation Guide (4445673 Rev. B 04/
2010). The volumes for the end repair step were then
doubled to accommodate the increase in volume of the
samples.
Bioinformatics analysis
For ChIP-seq analysis, 50-bp sequences from two bio-
logical replicates of the Hoxa2 ChIP and matched input
DNA controls (exp1 and exp2) were used. For exp1 only,
in response to the observation of poor end of read quality
scores, the ChIP and input sequences were truncated to
the ﬁrst 32 bp, using SOLiD_preprocess_ﬁlter_v1.pl (16)
(http://hts.rutgers.edu/ﬁlter/index.html). Sequence reads
were mapped to the NCBI37 (mm9/July 2007) release of
the mouse (Mus musculus) genome (including the mito-
chondrial genome of mouse) using Corona-Lite version
4.2.2 (Life Technologies). Uniquely mapped reads with a
maximum of ﬁve mismatches where converted into BED
format for downstream analysis.
Identiﬁcation of binding regions. The uniquely mapped
reads were analysed using the MACS version 1.4 b
software (17) (http://liulab.dfci.harvard.edu/MACS/) to
identify binding regions (excluding reads mapping to the
mitochondrial genome of mouse), using the matched input
DNA reads as a control. The summit of each binding
region is deﬁned as the location with the highest read
pileup. The bandwidth, mfold parameters were set to
250 and 10–30 respectively. The threshold P-value was
set to P< 1 105. Among the 18 226 regions from
‘exp2’, 8245 with false discovery rate (FDR) <10 were
selected for downstream analyses.
To associate Hoxa2-binding regions with potential
target genes, RefSeq transcript coordinates (Release 41)
were downloaded from the UCSC table browser and
associated, via GALAXY (18) (http://galaxy.psu.edu/),
with these regions. An association was made with one or
more genes if the summit of the binding regions
overlapped RefSeq transcripts or their promoter regions
(deﬁned as 10 to+2.5 kb of the TSS). If an overlap was
not observed then the closest gene (50 or 30 of the gene) was
selected.
The location of Hoxa2-binding regions, deﬁned by their
summit region coordinates (200 bp centred upon the
MACS deﬁned summit) relative to gene structure was
determined using CEAS version 0.9.9.8 (19) (http://
liulab.dfci.harvard.edu/CEAS/). The analysis was also
performed using a dataset containing the same number
of random genome coordinates (also 200 bp) selected
from mappable regions of the mouse genome. The
‘CRG Align 50’ data (containing all 50-mer with no
more than ﬁve mismatches relative to the mouse genome)
was downloaded from the test version of the UCSC
Genome Browser (http://genome-test.cse.ucsc.edu). The
ChIP-seq data has been submitted to ArrayExpress under
accession number E-MTAB-711.
Motif analysis. For motif discovery, over-represented
sequence motifs were identiﬁed in 200-bp regions
centered upon the summit of each binding region using
Weeder version 1.4.2 (20) (http://159.149.109.9/
modtools/). Matrices from the ‘Best Occurrences’ output
were compared against all TRANSFAC v11.3 matrices
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using the webtool STAMP (21) (http://benoslab.pitt.edu/
stamp/). Weblogos of the discovered matrices were created
using STAMP. Weeder was run using the following par-
ameters: S= scan both strands of the supplied sequences;
M=assume that there may be more than one discovered
motif per sequence; ‘medium’=search for motifs of
length 6 (one degenerate position), 8 (two degenerate pos-
itions) and 10 (three degenerate positions).
A PERL script was used to scan for motifs correspond-
ing to the Hox and Pbx consensus binding sequences
within 200 bp of Hoxa2-binding region summits and in
background sequences. The script identiﬁed matches
to a supplied IUPAC consensus sequence in the for-
ward and reverse strands of unmasked sequences. Two
background datasets were created by a PYTHON
script (generate_background_sequences.py) part of the
GimmeMotifs software package (22) (http://www.ncmls
.eu/bioinfo/gimmemotifs/). For each summit region
sequence a random sequence of the same length was
created using a ﬁrst order Markov Chain (modeling di-
nucleotide frequencies). A second set of sequences were
created containing sequence from a matched genomic
regions (relative to TSS).
Gene annotation analysis. The analysis of gene annotation
enrichment was performed using GREAT (23) (http://
great.stanford.edu/) using the ‘basal plus extension’ asso-
ciation rules and the whole mouse genome as background.
Statistical analysis. Fisher’s Exact chi-square test for 2 2
contingency tables (using two-tailed P-values; http://www
.quantitativeskills.com/sisa/) was applied in a number of
instances to determine whether the occurrence of consen-
sus sequences were signiﬁcantly different from back-
ground sequences.
ChIP–qPCR
ChIP–qPCR was performed on a Bio-Rad Chromo4
Real-time PCR system using SYBR green (Dynamo) ac-
cording to the manufacturer’s instructions (50 ml PCR
reaction for each primer set was performed using the fol-
lowing program: Step 1: 95C 15min; Step 2: 95C 30 s,
55C 1min, 72C 30 s, repeat 49 times; Step 3: melting
curve from 55C to 95C). Results were analyzed using
Bio-Rad Opticon Monitor 3.1.32. Fold enrichment of
each bound region was calculated over a negative
antibody control relative to input. In Figure 5A, values
are expressed as percent input for each bound region and
the corresponding negative antibody control. Primer se-
quences are listed in Supplementary Table S7.
Expression microarray
Second branchial arches of E11.0 and E11.5 embryos from
Hoxa2+/ intercrosses were dissected out and snap-frozen
in dry ice. After genotyping the embryos, pools were made
with the wild-type and Hoxa2/ branchial arches and
total RNA was extracted using Trizol. RNA quality was
checked using the RNA 6000 Nano Assay, and analyzed
on an Agilent 2100 Bioanalyser (Agilent Technologies).
RNA was quantiﬁed using a Nanodrop ultra-low-volume
spectrophotometer (Nanodrop Technologies). Labeled
targets were generated from total RNA (100 ng) using
the 30 IVT Express Kit and hybridized to GeneChip
Mouse Genome 430 2.0 arrays. The arrays were then
washed and stained using Fluidics Protocol FS450_0001
and images acquired using a GCS 3000HR scanner. The
intensity ﬁles (.cel) generated by GeneChip Command
Console (AGCC) software were then used for differential
expression analyses. Technical quality control was per-
formed with dChip (V2005) (www.dchip.org) (24) using
the default settings. Background correction, quantile nor-
malization and gene-expression analysis were performed
using RMA in Bioconductor (25). Principal component
analysis (PCA) was performed with Partek Genomics
Solution (version 6.5, Copyright 2010, Partek Inc., St.
Charles, MO, USA). Differential expression analysis was
performed using Limma using the functions lmFit and
eBayes (26). Gene lists of differentially expressed genes
were controlled for FDR errors using the method of
QVALUE (27). Microarray expression data has been
submitted to ArrayExpress under accession number E-
MEXP-3261.
RESULTS
Genome-wide mapping of Hoxa2-bound regions in the
developing second branchial arch
The second branchial arch (IIBA) is the embryonic area
most affected by inactivation of Hoxa2 in mouse. In the
absence of Hoxa2, the IIBA generates skeletal elements
typical of the more anterior ﬁrst branchial arch (IBA).
This abnormal skeletal development disrupts formation
of the middle ear. Hoxa2 expression appears in the IIBA
at E8.5 (28), following migration of Hoxa2-positive
cranial neural crest cells from the hindbrain, and it is
maintained throughout development of the IIBA.
Hoxa2-positive cells are still detected in IIBA derivatives
at later stages (E13.0). To deﬁne the genomic targets of
Hoxa2, we performed Hoxa2 ChIP-seq on IIBAs collected
at E11.5. Wild-type and Hoxa2 mutant embryos are
visually indistinguishable at this stage; shortly after
E11.5, the wild-type IIBA undergoes profound morpho-
logical changes to produce its ﬁnal derivatives. Most im-
portantly, Hoxa2 is strongly expressed in E11.5 IIBAs and
it is still required for IIBA development at this stage (29)
(Figure 1A).
DNA recovered from two independent Hoxa2 ChIP-seq
experiments was used to construct fragment libraries and
sequenced with the SOLID next generation sequencing
platform (Life Technologies). In the second of the two
experiments (exp2), we generated 12 242 621 and
16 973 356 uniquely mapping reads for Hoxa2 ChIP-seq
and input library respectively. MACS peak calling
software (17) identiﬁed 18 226 regions that are bound by
Hoxa2 in vivo (P< 1e–5), of which 8245 with FDR< 10.
The ﬁrst experiment (exp1) resulted in fewer binding
regions (less than one thousand) that almost entirely
overlapped with exp2, with 89.4% binding regions of
exp1 matching the entire set of binding regions detected
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in exp2 and 85% matching the subset of exp2-binding
regions with FDR< 10.
To establish the consistency of Hoxa2-bound regions,
we randomly selected 15 regions from the list of Hoxa2-
bound regions with FDR< 10 in exp2 and tested these by
ChIP–qPCR. We detected enrichment in the majority of
the regions tested (12/15) (Figure 1B, Supplementary
Figures S1 and S2). We therefore decided to concentrate
on the list of 8245 binding regions with FDR< 10 detected
in exp2, henceforth referred to as Hoxa2-bound regions
(Supplementary Table S3).
By submitting Hoxa2-bound regions to the Cis-regula-
tory Elements Analysis System (CEAS) software (19), we
found that a small fraction of Hoxa2 binding (2.4%) occur
in the vicinity (within 1 kb) of transcriptional start sites
(TSS); the occurrence of proximal promoters was 2-fold
enriched (P=2.46e–12) in Hoxa2-bound regions with
respect to background sequences. The majority of
Hoxa2-binding events (51.3%) occur at distances >10 kb
from any known TSS, and a large fraction (37.4%) are
located in introns (Figure 1C); these distributions indicate
that Hoxa2 binding is widely distributed across the
genome and slightly enriched at proximal promoters.
Hoxa2 ChIP-seq reveals abundance of Hox and
Pbx–Hox-binding sites
Hox proteins bind short AT-rich DNA sequences,
commonly containing a TAAT core (7,30,31). It is difﬁcult
to understand how Hox proteins ﬁnd their functional
binding sites in the genome using four- to six-letter recog-
nition sequences. Alternatively Hox short binding sites
may simply reﬂect the lack of a better-deﬁned recognition
sequence, owing to the relatively small number of in vivo
targets identiﬁed to date, and to the use of the
homeodomain (rather than the entire protein) in most of
the DNA-binding studies (7,32,33). Hoxa2 binds TAAT
in vitro and in vivo (34,35). Analysis of Hox functional
targets in vivo has shown that Hox can bind DNA co-
operatively with TALE homeodomain proteins, Pbx and
Meis (Exd and Hht in Drosphila) (7,36). To determine
Hoxa2-binding preferences, we analyzed the sequence of
Hoxa2-bound regions to search for over-represented
motifs. Using the de novo motif discovery software
(Weeder) (20) on 200-bp sequences centred upon each
binding region summit, we found that the ﬁve top most
highly ranked motifs could be categorized into three main
classes (Figure 2A). The sequence TAAT was the most
overrepresented motif; a longer version, ﬂanked by G
and T at 50 and 30 respectively, was also included in the
ﬁve top motifs identiﬁed by Weeder. The second most
overrepresented motif was TGATTGAT, which corres-
ponds to Pbx-binding site (37). A longer version of the
Pbx site also occurred at high frequency. Finally,
included in the ﬁve top ranked motifs, we found the
sequence TGATNNAT (where ‘N’ represents any nucleo-
tide; sequence is inverted in Figure 2A), previously
reported as a functional binding site for Pbx and
Figure 1. Detection of Hoxa2-ChIP-seq peaks in the IIBA. (A) Whole-mount ISH on E11.5 wild-type embryos, using Hoxa2 probe (left).
Magniﬁcation of the same picture shows the branchial area (right); the dotted line delimitates the IIBA. (B) ChIP–qPCR validation of FDR< 10
Hoxa2-bound regions. Fold enrichment of Hoxa2 over IgG negative control antibody (Neg Ab) is shown for each Hoxa2-bound region. Values represent
the average of duplicate samples and are adjusted to the average enrichment of Pou6f2 from two independent experiments. Itih4 is a negative control
(unbound region). For each sample the standard error of the mean is indicated by error bars. The dotted line represents a threshold of 2-fold or higher
signiﬁcant enrichment. (C) Distribution of Hoxa2 summit regions relative to Reference Sequence (RefSeq) gene structures. The pie charts indicate the
proportion of reads for each gene structure; the corresponding numeric values are included. For each pie chart, an enlargement of the boxed area is
shown above. CEAS detects signiﬁcant enrichment of proximal promoter in Hoxa2-bound regions compared to random regions (asterisks).
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Hox (7). We analyzed the distribution of these sequences
in Hoxa2-bound regions. When compared to random se-
quences, Hoxa2-summit regions were found to be signiﬁ-
cantly enriched in all the top ﬁve motifs identiﬁed by
Weeder (Figure 2B). The motif TAAT was present in
the majority of Hoxa2-summit regions (88.4%) and a
fraction of the Hoxa2-summit regions (18.4%) contained
the extended version, GTAATT. We detected combined
Pbx–Hox-binding sites in approximately one-third
(32.6%) of Hoxa2-bound regions. Finally, a fraction of
the Hoxa2-summit regions (7.9%) did not have any rec-
ognizable Hox or Pbx–Hox-binding site. The results above
show that Hoxa2-bound regions mainly contain Hox and
Pbx–Hox-binding sites. One third of Hoxa2-bound
regions can potentially host binding of Hoxa2 together
with its cofactor Pbx, but the largest fraction (60%)
contains single Hox-binding motifs. The identiﬁcation of
TAAT as the most overrepresented motif by de novo dis-
covery, and the signiﬁcant enrichment observed in Hoxa2-
bound regions, conﬁrms that albeit short, this DNA
sequence may indeed represent a functional recognition
site in vivo.
To identify additional overrepresented motifs, we
masked Hox (TAAT) and Pbx (TGAT) motifs in Hoxa2-
summit regions and performed again de novomotif discov-
ery. We found additional AT rich motifs; among those
only the sequence ATAAA was signiﬁcantly over-
represented in Hoxa2-summit regions when compared to
random sequences (55.5 and 48% in Hoxa2-bound regions
and background sequences, respectively; P=1.50e–20).
A well-established way in which Hox proteins achieve
speciﬁcity in vivo is to bind DNA cooperatively with other
DNA-binding factors. To identify factors interacting with
Hoxa2, we performed de novo motif discovery within the
100-nt ﬂanking each TAAT (50-nt upstream and down-
stream). We identiﬁed the sequence AATTA as the
most prominent motif, (21.8% occurrence; P=0.028).
We found a distance of 6–10 nt between the two motifs
(as deﬁned by their motif midpoints) in 19.5% of the
TAAT/ATTA pairs, suggesting the occurrence of palin-
dromic binding sites in Hoxa2-summit regions. By
scanning 100-nt sequences ﬂanking each TGATNNAT
motif, we found over-representation of the sequence TG
ACAG (occurrence in 8.4% of Hoxa2-summit regions
containing Pbx–Hox-binding sites; P=1.8e–25), which
corresponds to the recognition sequence of the Hox cofac-
tors Meis (Supplementary Figure S4). This ﬁnding
suggests that Meis factors preferentially interact with
Hoxa2 in the presence of Pbx. The over-representation
of recognition sites for well-known Hox cofactors (Pbx
and Meis) conﬁrms the quality of Hoxa2 ChIP-seq
regions. This result does not preclude that other factors
function in important combinations with Hoxa2, but it
suggests that no single transcription factor motif is
commonly used in the entire Hoxa2-occupied set. A
large fraction of Hoxa2-bound regions contains single
Hox-binding sites; ﬁnding speciﬁc combinations will
require focus on subsets of these regions selected by ex-
pression pattern of nearby genes.
Functional annotation links Hoxa2-peaks to the
development of the branchial arches
We used the web tool Genomic Regions Enrichment of
Annotations Tool (GREAT) (23) to identify terms
enriched in genes associated with Hoxa2-bound regions.
Consistent with a functional signiﬁcance of Hoxa2-
binding events, GREAT analysis speciﬁcally identiﬁed en-
richment of Hoxa2-bound regions near genes involved in
biological processes regulated by Hoxa2 in embryonic
development (Figure 3A). Hoxa2 loss-of-function affects
formation of the middle ear, and ectopic expression dis-
rupts development of the cranial skeleton (8–10,12,38–40).
Figure 2. Sequence analysis of Hoxa2-bound regions. (A) Sequence logo of the top ﬁve motifs identiﬁed using de novo motif discovery. (B) Analysis
of the distribution of motifs in Hoxa2-summit regions compared to background sequences. Red and yellow columns represent the occurrence of each
motif (indicated below each column pair) in Hoxa2-summit regions (red) and in background sequences (yellow). The numbers on top of each column
refer to the percentage of the peaks containing the motif. For all motifs shown, their occurrence in Hoxa2-bound regions was signiﬁcantly higher
than expected (only the exponent of the P-value is shown).
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Middle ear morphogenesis and embryonic skeletal mor-
phogenesis were identiﬁed in the top enriched biological
processes. GREAT detected over-representation of genes
expressed in the branchial arch in the gene-expression
ontology, and genes whose mutations generate phenotypes
such as middle ear abnormalities, delayed bone ossiﬁca-
tion and palatal development, another process controlled
by Hoxa2 (41).
Most interestingly, GREAT detected a strong enrich-
ment of Hoxa2-regions near genes involved in the
‘Wnt-signaling pathway’, ranked as the top category.
A closely related category, ‘regulation of Wnt-signaling
pathway’, was also included in the top enriched biological
processes. This novel association uncovers a potential role
for Wnt signaling to instruct IIBA development down-
stream of Hoxa2.
Next, we classiﬁed regions according to the presence of
Hox, Pbx–Hox, both Hox and Pbx–Hox, or no motif in
their summit, and performed GREAT analysis on each
class (Figure 3B). Consistent with each binding site (or
Figure 3. Functional annotation of Hoxa2-bound regions. (A) Top over-represented categories in the Gene Ontology (GO) (blue), Mouse pheno-
types (green) and Mouse expression (red). GO describes the biological processes associated with gene function; mouse phenotypes ontology contains
data about mouse genotype–phenotype associations; Mouse Genome Informatics (MGI) expression contains information on tissue- and
developmental-stage-speciﬁc expression in mouse. The number of genes contained in each category is indicated in brackets. The length of the
bars corresponds to values on the x-axis, which are binomial raw (uncorrected) P- values. TS: Theiler Stage. (B) Top overrepresented categories
in the Gene Ontology (GO) in Hoxa2-bound regions containing Hox (red), Hox-Pbx (purple), Hox and Hox-Pbx (blue), and no motif (turquoise).
The proportion of peaks containing the different motifs with respect to the total of Hoxa2-bound regions is shown in the pie chart (together with
percentage values for each fraction); for each class, the top ﬁve categories with P< 106 are shown.
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their combination) having different functional outputs, we
found that peaks containing Hox, Pbx–Hox or both
binding sites were associated with genes involved in differ-
ent biological processes. Binding regions containing a
Hox-binding site had a similar proﬁle to the one in
Figure 3A, possibly because they constitute the largest
class. We found the second largest class of peaks
(28.7%; containing both Hox and Pbx–Hox-binding
sites) to be enriched in genes involved in fewer speciﬁc
processes, artery and middle ear development and
neuron differentiation. Most notably ‘Wnt-signaling
pathway’, the most overrepresented category in the
previous class (and in the totality of Hoxa2 ChIP-seq
peaks) was not included in the top overrepresented bio-
logical processes associated with peaks containing Hox
and Pbx–Hox-binding sites. Regions containing only
Pbx–Hox-binding sites were linked to genes involved in
embryogenesis. Strikingly, peaks containing no Hox or
Pbx–Hox-binding sites were exclusively and speciﬁcally
associated with genes involved in bone formation. A
simple explanation to this observation is that Hoxa2
binds these genomic regions via an additional transcrip-
tion factor, possibly involved in regulation of bone.
However, performing de novo motif discovery on this
class of Hoxa2-peaks did not identify any known
overrepresented motif. Finally, GREAT did not detect
enrichment of gene ontology terms in the class of
Hoxa2-peaks containing Pbx-binding site (i.e. the subset
of the Pbx–Hox peaks containing Pbx recognition se-
quence TGATTGAT).
Identiﬁcation of functional locus occupancy by Hoxa2 in
E11.5 developing embryos
Next, we assigned Hoxa2-bound regions to genes. Using
the nearest gene approach, we assigned 8245 Hoxa2-
bound regions to a total of 3579 genes. A survey of the
genes previously identiﬁed as regulated by Hoxa2 during
embryonic development showed that 8 of 15 genes had at
least one Hoxa2-bound region associated with them
(Supplementary Table S5).
To assess the effect of Hoxa2 DNA binding on gene
expression, we used microarrays in the same embryonic
populations as those interrogated by ChIP-seq. By
comparing E11.5 wild-type and Hoxa2-null mutant bran-
chial arches, we identiﬁed 489 differentially expressed
genes (fold difference> 1.3; P< 0.05) of which 359 and
130 were down and upregulated in mutant embryos,
respectively. If Hoxa2-bound regions are functionally
active, we should expect a marked enrichment of
ChIP-seq genes in the genes dysregulated in Hoxa2
mutant branchial arches. We found that 48% (237/489)
of Hoxa2-regulated genes had at least one Hoxa2-bound
region assigned to them, which represents a highly signiﬁ-
cant enrichment compared with all genes (P=1.1e–106)
(Figure 4A). Upon separating Hoxa2-regulated genes into
down and upregulated, we found that 50% and 42% of
the genes down and upregulated in the Hoxa2 mutant,
respectively, had at least one Hoxa2-bound region
assigned to them (P=8.9e–87 and 4.2e–23, respectively)
(Supplementary Table S6). These results suggest that
nearly half of the genes that are dysregulated in the
Hoxa2 mutant are directly regulated (either positively or
negatively) by Hoxa2.
The list of bound and regulated genes included known
functional targets of Hoxa2 (Robo2 and Six2) (15,34,42),
genes whose expression is affected in the Hoxa2 mutant
(Runx2 andMsx1) (12,29) andHox genes themselves, con-
sistent with Hox cross-regulation (43–47). Most interest-
ingly, previously unknown targets included Meis1 and
Meis2, whose protein products function as Hox cofactors
(7,36), suggesting a positive regulatory loop between Hox
and Meis proteins.
Further characterization of these putative Hoxa2 direct
targets revealed 654 and 168 Hoxa2-bound regions
associated with down and upregulated genes, respectively.
The average number of Hoxa2-bound regions per gene
was 3.6 and 3 for down and upregulated genes, respect-
ively, which is signiﬁcantly higher than the average of the
ChIP-seq genes (Figure 4B). By analyzing the genomic
distribution of Hoxa2-bound regions, we found a higher
instance of promoters in Hoxa2-bound regions associated
with regulated genes, compared to the totality of
Hoxa2-bound regions. In contrast, Hoxa2-bound regions
associated with down and upregulated genes were not
preferentially localized to other genomic features (down-
stream, introns, intergenic) (Figure 4C).
We then asked if the occurrence of TAAT and
TGATNNAT, identiﬁed as top enriched motifs in
Hoxa2-peaks, was similar in Hoxa2-bound regions
associated with down and upregulated genes. We
detected a higher occurrence of TAAT in Hoxa2-bound
regions associated with upregulated genes (P=0.0018)
compared to the totality of Hoxa2-bound regions
(Figure 4D). To assess the effects of each binding site
(or their combination) on gene expression, we classiﬁed
Hoxa2-bound regions associated to upregulated and
downregulated genes according to the presence of Hox,
Pbx–Hox, both Hox and Pbx–Hox, or no motif. We
found that ‘Hox’ regions are signiﬁcantly over-represented
in upregulated genes (P=0.016) compared to down-
regulated genes (Figure 4E), indicating that TAAT pref-
erentially occurs alone in sequences associated to
repressed genes. The distributions of the remaining
classes of Hoxa2-bound regions did not signiﬁcantly
differ in upregulated and downregulated genes; however,
it is interesting to notice the lower frequency of ‘no motif’
sequences in upregulated genes compared to
downregulated genes (P=0.077).
In summary, Hoxa2 binds more frequently in the sur-
rounding of regulated genes. Repressed genes display a
signiﬁcantly higher occurrence of Hox-binding sites
alone in their binding regions, than activated genes. This
result may reﬂect different effects of Hoxa2 on the tran-
scriptional output when alone or in a complex with Pbx.
Finally, we used Hoxa2-bound regions associated with
down and upregulated genes to reﬁne the Hoxa2 recogni-
tion site identiﬁed by de novo motif discovery (Figure 2A).
Our search did not identify any obvious sequence restric-
tion beyond the TAAT core motif, only a mild preference
for T to follow, and the tendency to be embedded in
stretches of AT-rich sequences (Figure 4F).
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Hoxa2 controls Wnt–b-catenin-signaling pathway
in the IIBA
The ﬁnding that Hoxa2-bound regions are associated to
genes in the ‘Wnt-signaling pathway’ and ‘regulation of
Wnt-signaling pathway’ categories, suggests that Hoxa2
may act upstream of the Wnt-signaling pathway in the
IIBA. Veriﬁcation of Hoxa2 binding on a subset of
the regions linked to genes in the Wnt-signaling pathway
by conventional ChIP–qPCR, conﬁrmed that eight out of
eight binding regions were bound by Hoxa2 in vivo (Figure
5A). Twelve of the 81 genes linked to ‘Wnt-signaling
pathway’ and ‘regulation of Wnt-signaling pathway’
categories and associated with Hoxa2-bound regions,
were differently regulated in microarrays comparison of
E11.5 wild-type and mutant IIBA (Figure 5B). Among
these 81 genes we found Wnt5a, whose inactivation in
mouse affects outer ear development and Fzd4, previously
identiﬁed as differentially expressed in a screen performed
on E10.5 Hoxa2 mutant (our unpublished observation).
ISH hybridization revealed expression of Fzd4 and
Wnt5a in the IIBA of E10.5, and in the developing outer
ear of E12.0 wild-type embryos, respectively (Figure 5C
and E). Both expression domains were absent in the
Hoxa2 mutant (Figure 5D and F). Next, we used
BAT-GAL mice (11) to investigate the state of canonical
Wnt–b-catenin signaling in the IIBA. At E11.5, the IIBA
exhibits strong, localized b-galactosidase activity (Figure
5G). Wnt–b-catenin-signaling activity is greatly reduced in
the IIBA of Hoxa2 mutant embryos, where the staining
appears comparable to the one in the IBA (Figure 5H).
Low b-galactosidase activity was detected in the IIBA of
younger embryos (E10.5); this activity was comparable in
wild-type and mutant embryos (not shown). At E13.0
b-galactosidase -positive cells labeled the pinna of the
outer ear, which is Hoxa2-positive at the same stage
(Figure 5I and J).
Figure 4. Intersection between ChIP-seq data and gene-expression analysis. (A) Venn diagram showing the overlap between the genes associated with
Hoxa2-bound regions (blue) and those revealed by expression arrays. (B) Average number of Hoxa2-bound regions per gene in the entire ChIP-seq
dataset (grey), Hoxa2-bound regions associated with down- (green) and up- (red) regulated genes. On average down- and upregulated genes are
associated with a higher number of Hoxa2-bound regions (P=2.2e–16 and 0.001, respectively). (C) Distribution of Hoxa2 summit regions relative to
Reference Sequence (RefSeq) gene structures: promoter (10-kb upstream of the TSS), transcript, and downstream (10-kb downstream of the TTS).
Hoxa2-summit regions associated with down and upregulated genes occur more frequently in promoters compared to the entire ChIP-seq dataset
(P=0.05 and 0.005, respectively); the color code is as in (B). (D) Analysis of the distribution of Hox and Pbx–Hox motifs in Hoxa2-summit regions
associated with down- and upregulated genes [color code as in (B)]. TAAT is signiﬁcantly enriched in Hoxa2-bound regions associated with
upregulated genes. The numbers on top of each column refer to the percentage of Hoxa2-summit regions containing the motif. (E) Distribution
of Hoxa2-bound regions containing Hox (red), Hox-Pbx (purple), Hox and Hox-Pbx (blue), and no motif (turquoise) in regulated genes. Numbers
indicate the contribution of each class to the total of Hoxa2-bound regions associated to upregulated genes (inner ring), downregulated genes (middle
ring) and the entire Hoxa2 data set (outer ring). (F) Extension of the TAAT motif in down- and upregulated genes. Plots of the density of each
nucleotide around each TAAT motif contained in Hoxa2-summit regions associated with up and downregulated genes.
Nucleic Acids Research, 2012, Vol. 40, No. 9 3997
These ﬁndings indicate that Hoxa2 activates the
canonical Wnt–b-catenin-signaling pathway in the IIBA.
This Hoxa2-dependent Wnt–b-catenin activity is ﬁrst
observed in E11.5 IIBA. It is maintained at least
until E13.0, when it is detected in the pinna, a
IIBA-derivative that fails to form in the Hoxa2 mutant.
In addition, the observed downregulation of Wnt5a in
the Hoxa2 mutant suggests Hoxa2 may also regulate
Wnt non-canonical, b-catenin independent pathways in
the IIBA.
DISCUSSION
Hox proteins are key transcription factors in the
antero-posterior (AP) patterning of the embryo, but the
molecular basis of Hox function is proving difﬁcult to
understand. This analysis of Hoxa2 in vivo occupancy
provides the basis to learn how Hox proteins binding to
the genome informs embryonic development, and the
structure of the body plan.
In view of their accurate snapshot of the biological
processes downstream of Hoxa2, Hoxa2 ChIP-seq data
provide real opportunities to disclose additional processes
controlled by Hoxa2 (and possibly Hox proteins) in de-
velopment and disease. We show here that Hoxa2 regu-
lates the Wnt-signaling pathway, a ﬁnding uncovered
solely on the basis of gene association to Hoxa2-bound
regions, and we provide the molecular coordinates
through which this control is executed. Hoxa2-peaks are
frequently detected in the surroundings of genes
associated to ‘Wnt-signaling pathway’ ontology deﬁn-
itions. Further investigation has revealed a stage- and
Figure 5. Hoxa2 is upstream of Wnt–b-catenin signaling. (A) Validation of binding regions linked to genes in the Wnt-signaling pathway by ChIP–
qPCR. Percent Input is shown for each Hoxa2-bound region and the corresponding negative antibody control (Neg Ab). Values represent the
average of duplicate samples. Art3 is a negative control gene (unbound region). (B) The differentially expressed genes (from the list in Supplementary
Table S6) linked to Wnt GO categories are shown together with their corresponding fold changes. (C–F) Expression of Fzd4 and Wnt5a in wild-type
(C, E) and mutant (D, F) embryos. In situ hybridization on whole mount E10.5 wild-type and Hoxa2 mutant (C, D) and E12.5 wild-type and Hoxa2
mutant (E, F) using Fzd4 (C, D) and Wnt5a (E, F) probes. Arrow in (C) and (D), and arrowhead in (E) and (F), indicate the embryonic area where
Fzd4 and Wnt5a are downregulated in the mutant, respectively. (G and H). Whole mount lacZ staining of E11.5 BAT-Gal (G) and BAT-Gal;
Hoxa2/ (H) embryos. (G) High Wnt canonical activity is detected in the IIBA of E11.0 BAT-Gal transgenic embryos. (H) Wnt canonical activity is
lost in the IIBA (arrow) in the absence of Hoxa2. Dotted line separates IIBA from IBA. (I and J) BAT-Gal (I) and wild-type (J) E13.0 embryos.
(I) Wnt canonical activity is mostly conﬁned to the pinna of the outer ear (arrowhead). (J) In situ hybridization using Hoxa2 probe shows the pinna
remains Hoxa2 positive at later stages (arrowhead). Ea, ear; e, eye.
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tissue-speciﬁc activation of canonical Wnt–b-catenin sig-
naling in Hoxa2 main domain of expression, which mani-
fests exclusively in the presence of Hoxa2. Later in
development, canonical Wnt–b-catenin signaling remains
highly active in the outer ear outgrowth, which fails to
form in the Hoxa2 mutant. Interestingly, the outer
ear also develops abnormally following mesenchymal
inactivation of b-catenin in the branchial arches (48).
Collectively, these observations suggest that canonical
Wnt–b-catenin signaling controls morphogenesis of the
outer ear downstream of Hoxa2. The full understanding
of Hoxa2 control of Wnt signaling requires characterizing
the role and the contribution of Hoxa2-regulated events to
Wnt–b-catenin activity in the IIBA. A ﬁrst and essential
step in this direction will be to correlate Wnt–b-catenin
activity, which is regionally restricted in the IIBA, to the
spatial expression of the individual Hoxa2 targets. Hoxa2
activation of Fzd4 is predicted to have a positive effect on
Wnt–b-catenin signaling: Fzd4 serves as a receptor in
Wnt–b-catenin and in non-canonical Wnt signaling (49–
51), it is largely expressed in the IIBA, and loss of Fzd4
expression and of Wnt–b-catenin signaling is simultan-
eously observed in the Hoxa2 mutant. We also show
here that Hoxa2 regulates Wnt5a, which is required for
outer ear formation (52). Although Wnt5a preferentially
signals via non-canonical pathways, it can both inhibit
and activate Wnt–b-catenin signaling (and the latter
requires the presence of Fzd4) (51,53).
Wnt is one of the few signaling pathways utilized to
pattern organs and specify cell fate during embryonic de-
velopment, and Hox proteins are key regulators of embry-
onic development, but surprisingly few instances of Hox
regulation of Wnt have been described in vertebrate de-
velopment (54,55). The ability to modify the activity of
signaling pathways can change the local morphogenetic
programs and generate segment-speciﬁc structures (56),
and, in few cases, Hox proteins have been shown to
modify the activity of the signaling pathways the cells
are exposed to (57,58). From this perspective, Hoxa2
control of the Wnt-signaling pathway represents a per-
fectly suitable mechanism to generate second branchial
arch-speciﬁc positional information.
Hox proteins bind AT-rich DNA sequences, centered
on a TAAT core (7,30,31). The use of short and very
similar recognition sequences does not explain the high
speciﬁcity displayed by Hox proteins in vivo. We ﬁnd
that TAAT is the top enriched motif in Hoxa2-bound
regions, and is signiﬁcantly more enriched in Hoxa2-
bound regions associated to repressed genes. GTAAT
and TGANNAT, the additional motifs identiﬁed by
sequence analysis, display a higher over representation
in Hoxa2-bound regions (compared to background se-
quences) with respect to TAAT. The functional signiﬁ-
cance of GTAAT is unclear, as effort to extend Hoxa2
recognition sequence using ‘conﬁdent’ Hoxa2-bound
regions (i.e. the ones linked to regulated genes) did not
identify any strict sequence restriction beyond the TAAT
core motif. Together, GTAATT and TGATNNAT could
determine the speciﬁcity of about half Hoxa2-binding
events (they are contained in 45% of Hoxa2-bound
regions). The remaining half of Hoxa2 summit regions
contains only TAAT, or no recognizable Hox or
Hox-Pbx-binding site (8%), suggesting that additional
unknown mechanisms are in place to determine speciﬁcity.
Their discovery may require focus on subsets of regions
selected by similar functions or by expression pattern of
nearby genes.
Binding short, highly frequent motifs obviously does
not help to discriminate functional targets, but provides
large genome coverage, which may be important for add-
itional functions. In a developmental context, Hox
proteins endow cells with positional identity, to inform
cells of the appropriate type of structure to be built in
that speciﬁc body position. A possibility is that Hoxa2,
in addition to regulating a speciﬁc set of target genes
(possibly selected with the help of cofactors), acts as a
‘pioneer’ transcription factor and binds early chromatin
to prepare for the subsequent steps of cell differentiation,
i.e. recruitment of tissue-speciﬁc transcriptional regula-
tors. Widespread genome coverage may also provide a
built-in redundancy to Hoxa2 regulation, for the poten-
tial to bind in the vicinity of many genes, and to control
downstream molecular mechanisms via multiple com-
ponents. Indeed, a survey of the genes associated to
Hoxa2-bound regions reveals many instances of homolo-
gous genes, a feature already evident within the restricted
group of genes reported as Hoxa2 direct and functional
targets (15,35,42). Hoxa2 ChIP-seq reveals binding in or
around genes that are closely related to Six2 (Six1 and
Six4), Robo2 (Robo1) and Meox1 (Meox2).
Mapping of binding sites across the genome reveals that
Hoxa2 has large genome coverage, but we ﬁnd that the
majority of the regions bound by Hoxa2 at E11.5 are
associated to genes with no evidence of dysregulation in
Hoxa2mutant IIBA. The binding proﬁle of Hoxa2 reﬂects
a mixture of binding sites from many different cell types
that are sampled simultaneously from the entire IIBA.
Simple biological possibilities are that many binding
sites may have functional relevance at developmental
stages different from the one assayed, in different tissues
where Hoxa2 is active, or in unusual circumstances, such
as the absence of other transcription factors. Furthermore
binding sites that reﬂect ﬁne-tuning regulation of gene
expression are likely to be associated to expression
changes below the cutoff applied to identify genes differ-
entially expressed in the Hoxa2 mutant. An alternative
possibility is that Hoxa2 binds promiscuously to many
regions within portions of the genome that are physically
accessible to it and much of this occupancy may not be
associated with any regulatory activity. Relating the
global Hoxa2 occupancy pattern to functional cis-regula-
tory modules (CRM) activity will be crucial to understand
how many of these binding events are functionally
relevant and to construct a reliable Hoxa2 regulatory
network.
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